Clinical trial
AIR Extension Study - Long-Term Safety of Alair Treated Subjects
NCT00448812 · Boston Scientific Corporation, Industry · Completed
Key facts
| NCT number | NCT00448812 |
|---|---|
| Title | AIR Extension Study - Long-Term Safety of Alair Treated Subjects |
| Official title | Extension Study for the Multicenter Randomized Clinical Trial of the Alair® System for the Bronchial Thermoplasty Treatment of Asthma (NCT00214526) |
| Acronym | AIRx |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Device |
| Interventions | Bronchial Thermoplasty with the Alair System |
| Enrollment | 69 |
| Start date | Mar 1, 2005 |
| Primary completion | Dec 1, 2009 |
| Completion | Apr 1, 2010 |
| First posted | Mar 19, 2007 |
| Last update posted | Feb 17, 2021 |
| Countries | Brazil, Canada, United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: